EMEA-000239-PIP01-08-M03

  • Email
  • Help

Overview

Product details for Vibativ
Invented nameVibativ
Active substance

Telavancin (hydrochloride)

Decision numberP/0354/2017
PIP numberEMEA-000239-PIP01-08-M03
Pharmaceutical form(s)Powder for concentrate for solution for infusion
Condition(s)/indication(s)

Treatment of nosocomial pneumonia

Treatment of complicated skin and soft tissue infections (cSSTI)

Route(s) of administrationIntravenous use
PIP applicant

Theravance Biopharma Ireland Ltd.
Tel. +33 174882008
E-mail: marine.lafargue@quintilesims.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision

Related information